Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,162 | 1,260 | 99.5% |
| Education | $94.32 | 8 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,209 | 169 | $0 (2024) |
| ABBVIE INC. | $1,725 | 119 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,440 | 140 | $0 (2024) |
| Lilly USA, LLC | $1,432 | 93 | $0 (2024) |
| PFIZER INC. | $1,211 | 134 | $0 (2024) |
| Amgen Inc. | $1,133 | 73 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $932.33 | 60 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $790.88 | 44 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $565.34 | 54 | $0 (2024) |
| Amarin Pharma Inc. | $525.77 | 34 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,498 | 90 | Novo Nordisk Inc ($266.87) |
| 2023 | $3,167 | 192 | Novo Nordisk Inc ($463.88) |
| 2022 | $3,280 | 226 | ABBVIE INC. ($441.15) |
| 2021 | $3,150 | 227 | AbbVie Inc. ($537.34) |
| 2020 | $1,636 | 124 | Novo Nordisk Inc ($316.07) |
| 2019 | $1,499 | 129 | PFIZER INC. ($268.31) |
| 2018 | $1,509 | 124 | Novo Nordisk Inc ($173.14) |
| 2017 | $1,517 | 156 | Allergan Inc. ($272.86) |
All Payment Transactions
1,268 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Gastroenterology | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Gastroenterology | ||||||
| 07/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Gastroenterology | ||||||
| 06/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: DIABETES | ||||||
| 06/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Diabetes | ||||||
| 06/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Endocrinology | ||||||
| 06/14/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Obesity | ||||||
| 06/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $0.51 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Cardiology | ||||||
| 06/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Obesity | ||||||
| 06/07/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $19.66 | General |
| Category: Endocrinology | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Gastroenterology | ||||||
| 05/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: PSYCHIATRY | ||||||
| 05/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes | ||||||
| 05/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Bone Health | ||||||
| 05/23/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $28.09 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Diabetes | ||||||
| 05/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.05 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,488 | 2,405 | $284,077 | $159,815 |
| 2022 | 19 | 1,680 | 2,615 | $291,161 | $164,735 |
| 2021 | 19 | 1,740 | 2,632 | $295,093 | $172,972 |
| 2020 | 19 | 1,828 | 2,735 | $289,597 | $154,121 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 557 | 1,065 | $159,750 | $86,246 | 54.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 330 | 515 | $51,500 | $27,899 | 54.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 73 | 88 | $16,280 | $10,949 | 67.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 136 | 139 | $11,815 | $9,981 | 84.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $8,075 | $5,341 | 66.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 22 | 95 | $9,500 | $5,337 | 56.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 145 | 149 | $5,960 | $4,388 | 73.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $4,290 | $2,709 | 63.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 28 | $4,160 | $2,198 | 52.8% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 20 | 59 | $3,835 | $1,691 | 44.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 12 | 12 | $2,340 | $1,673 | 71.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 64 | 67 | $4,690 | $581.73 | 12.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $760.00 | $559.55 | 73.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 32 | 35 | $350.00 | $119.35 | 34.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 82 | $574.00 | $82.31 | 14.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 11 | 11 | $198.00 | $58.50 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 568 | 1,037 | $155,595 | $83,805 | 53.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 338 | 515 | $51,500 | $28,954 | 56.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 93 | 119 | $22,015 | $14,450 | 65.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 158 | 158 | $13,430 | $10,829 | 80.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 178 | 178 | $7,120 | $5,036 | 70.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 21 | 72 | $6,480 | $3,700 | 57.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $5,100 | $3,337 | 65.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 25 | 25 | $4,735 | $3,134 | 66.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 16 | 16 | $2,500 | $2,122 | 84.9% |
About Dr. Greg Ehgartner, D.O
Dr. Greg Ehgartner, D.O is a Internal Medicine healthcare provider based in Camp Hill, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346230158.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Greg Ehgartner, D.O has received a total of $17,256 in payments from pharmaceutical and medical device companies, with $1,498 received in 2024. These payments were reported across 1,268 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($17,162).
As a Medicare-enrolled provider, Ehgartner has provided services to 6,736 Medicare beneficiaries, totaling 10,387 services with total Medicare billing of $651,643. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Camp Hill, PA
- Active Since 10/24/2005
- Last Updated 10/19/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346230158
Products in Payments
- Ozempic (Drug) $1,038
- XIFAXAN (Drug) $948.15
- TRELEGY ELLIPTA (Drug) $786.56
- ELIQUIS (Drug) $614.10
- QULIPTA (Drug) $570.20
- VRAYLAR (Drug) $527.79
- Vascepa (Drug) $525.77
- EVENITY (Biological) $515.89
- TRULICITY (Drug) $478.99
- MOUNJARO (Drug) $471.70
- Rybelsus (Drug) $450.22
- FARXIGA (Drug) $418.00
- ENTRESTO (Drug) $408.95
- XARELTO (Drug) $361.98
- NURTEC ODT (Drug) $343.04
- JARDIANCE (Drug) $328.84
- TRADJENTA (Drug) $288.46
- UBRELVY (Drug) $257.48
- LINZESS (Drug) $241.52
- Aimovig (Biological) $235.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Camp Hill
Rena Dearment, Md, MD
Internal Medicine — Payments: $290,160
Nayanjyoti Kaushik, M.d, M.D
Internal Medicine — Payments: $57,720
Eric Binder, M.d, M.D
Internal Medicine — Payments: $18,034
Stephanie Madonis
Internal Medicine — Payments: $13,739
Harinidevi Krishnan, M.d, M.D
Internal Medicine — Payments: $12,862
Namrata Haldipur, M.d, M.D
Internal Medicine — Payments: $12,697